Results from a survey conducted by Certification Commission for Health Information Technology showed healthcare providers find some stage 2 meaningful objectives too aggressive, according to a post on EHR Decisions by CCHIT Chair Karen Bell, MD.
A total of 468 individuals, representing healthcare providers, electronic health records vendors and other industry stakeholders, responded to the survey. Key findings from the survey include the following:
• More than 50 percent of healthcare providers and 40 percent of EHR vendors and others felt that syndromic surveillance should not be a core measure for stage 2 meaningful use. The remainder of respondents felt a significant amount of resources and effort would be needed if syndromic surveillance did become a core measure.
• Respondents want to include medication reconciliation as a core measure in stage 2 but do not want the percent of patients to which it applies to increase until stage 3 because few providers are actually carrying this out in stage 1.
• Many respondents felt clinical decision support needed a better infrastructure with more established support rules before going beyond stage 1.
Read the blog post by Dr. Karen Bell about the CCHIT survey findings.
Read other coverage about stage 2 meaningful use:
- Stage 2 Quality Measures Panel to Decide Whether to Follow Same Structure as Stage 1
- PPR: Patient Security Lacking in Stage 2 Meaningful Use
- 39 Medical Societies Call EHR Incentive Program Imperfect Fit for Physicians
A total of 468 individuals, representing healthcare providers, electronic health records vendors and other industry stakeholders, responded to the survey. Key findings from the survey include the following:
• More than 50 percent of healthcare providers and 40 percent of EHR vendors and others felt that syndromic surveillance should not be a core measure for stage 2 meaningful use. The remainder of respondents felt a significant amount of resources and effort would be needed if syndromic surveillance did become a core measure.
• Respondents want to include medication reconciliation as a core measure in stage 2 but do not want the percent of patients to which it applies to increase until stage 3 because few providers are actually carrying this out in stage 1.
• Many respondents felt clinical decision support needed a better infrastructure with more established support rules before going beyond stage 1.
Read the blog post by Dr. Karen Bell about the CCHIT survey findings.
Read other coverage about stage 2 meaningful use:
- Stage 2 Quality Measures Panel to Decide Whether to Follow Same Structure as Stage 1
- PPR: Patient Security Lacking in Stage 2 Meaningful Use
- 39 Medical Societies Call EHR Incentive Program Imperfect Fit for Physicians